The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia.

IF 5.3 2区 医学 Q2 IMMUNOLOGY
Inflammopharmacology Pub Date : 2025-09-01 Epub Date: 2025-08-12 DOI:10.1007/s10787-025-01888-7
Pooja Wagaskar, Sayali Gaikwad, Meghraj Suryawanshi, Ashwani Patil
{"title":"The link between oral health and neurodegeneration: a review of periodontitis in Alzheimer's and Parkinson's disease and dementia.","authors":"Pooja Wagaskar, Sayali Gaikwad, Meghraj Suryawanshi, Ashwani Patil","doi":"10.1007/s10787-025-01888-7","DOIUrl":null,"url":null,"abstract":"<p><p>This review aims to explore the relationship between periodontitis and neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and dementia. It also aims to evaluate the existing evidence and discuss whether periodontitis could be considered a modifiable risk factor in the prevention or progression of neurodegenerative conditions. Neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia are among the most challenging health issues of our time, especially with aging populations worldwide. Interestingly, recent research suggests that the health of our mouth-particularly chronic gum disease known as periodontitis-might be more closely linked to brain health than we ever realized. This review explores the growing body of evidence connecting periodontitis with neurodegeneration. We examine how oral bacteria and the inflammation they cause can enter the bloodstream, reach the brain, and potentially trigger or worsen conditions like Alzheimer's and Parkinson's disease. From preclinical models to clinical trials, the data show intriguing overlaps in the biological pathways involved, particularly inflammation, immune responses, and abnormal protein accumulation. While more research is still needed to confirm direct cause-and-effect relationships, the existing findings raise an important question: could improving oral health be a simple, preventive step toward protecting the brain? This review aims to shed light on that possibility and encourages further exploration into treating periodontitis not just as a dental issue, but as a potential key to slowing down or preventing neurodegenerative diseases.</p>","PeriodicalId":13551,"journal":{"name":"Inflammopharmacology","volume":" ","pages":"5023-5036"},"PeriodicalIF":5.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10787-025-01888-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This review aims to explore the relationship between periodontitis and neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and dementia. It also aims to evaluate the existing evidence and discuss whether periodontitis could be considered a modifiable risk factor in the prevention or progression of neurodegenerative conditions. Neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia are among the most challenging health issues of our time, especially with aging populations worldwide. Interestingly, recent research suggests that the health of our mouth-particularly chronic gum disease known as periodontitis-might be more closely linked to brain health than we ever realized. This review explores the growing body of evidence connecting periodontitis with neurodegeneration. We examine how oral bacteria and the inflammation they cause can enter the bloodstream, reach the brain, and potentially trigger or worsen conditions like Alzheimer's and Parkinson's disease. From preclinical models to clinical trials, the data show intriguing overlaps in the biological pathways involved, particularly inflammation, immune responses, and abnormal protein accumulation. While more research is still needed to confirm direct cause-and-effect relationships, the existing findings raise an important question: could improving oral health be a simple, preventive step toward protecting the brain? This review aims to shed light on that possibility and encourages further exploration into treating periodontitis not just as a dental issue, but as a potential key to slowing down or preventing neurodegenerative diseases.

口腔健康与神经退行性变之间的联系:阿尔茨海默病、帕金森病和痴呆症牙周炎的综述。
本文旨在探讨牙周炎与神经退行性疾病,如阿尔茨海默病、帕金森病和痴呆的关系。它还旨在评估现有的证据,并讨论牙周炎是否可以被认为是预防或进展神经退行性疾病的可改变的危险因素。神经退行性疾病,如阿尔茨海默氏症、帕金森氏症和痴呆症,是我们这个时代最具挑战性的健康问题之一,尤其是在全球人口老龄化的情况下。有趣的是,最近的研究表明,我们的口腔健康——尤其是被称为牙周炎的慢性牙龈疾病——与大脑健康的关系可能比我们意识到的更密切。这篇综述探讨了越来越多的证据将牙周炎与神经变性联系起来。我们研究口腔细菌及其引起的炎症如何进入血液,到达大脑,并可能引发或加重阿尔茨海默病和帕金森病等疾病。从临床前模型到临床试验,数据显示了相关生物学途径的有趣重叠,特别是炎症、免疫反应和异常蛋白质积累。虽然还需要更多的研究来证实直接的因果关系,但现有的发现提出了一个重要的问题:改善口腔健康是否可以成为保护大脑的一个简单的预防性步骤?这篇综述旨在阐明这种可能性,并鼓励进一步探索治疗牙周炎不仅是牙科问题,而且是减缓或预防神经退行性疾病的潜在关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Inflammopharmacology
Inflammopharmacology IMMUNOLOGYTOXICOLOGY-TOXICOLOGY
CiteScore
8.00
自引率
3.40%
发文量
200
期刊介绍: Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn''s disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas: -Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states -Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs -Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents -Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain -Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs -Muscle-immune interactions during inflammation [...]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信